Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
Raid Alpine 2022: Team take on the Alps
Setting off on 4 July, 22 dedicated challenge cyclists took on the Raid Alpine route, cycling 770 kilometres through some of the most feared climbs, to raise funds for Cure Parkinson’s and support the charity’s search for a cure.
Dr Simon Stott appointed to Director of Research at Cure Parkinson’s
21 June 2022 Cure Parkinson’s is pleased to announce that Dr Simon Stott, current Deputy Director of Research at Cure Parkinson’s, has been promoted to the role of Director of Research. Simon will lead on fostering promising new lines of research, and continue to promote…
The influence of diabetes on Parkinson’s progression
In recent research funded by Cure Parkinson’s, scientists have provided the strongest evidence to date that diabetes can affect the progression of Parkinson’s.
Inhibikase makes a case for c-Abl
Research has suggested that in some cases of Parkinson’s a protein called c-Abl tyrosine kinase is abnormally over-active and this contributes to nerve cell inflammation and eventual cell death. The biotech company, Inhibikase, has been developing a drug which dampens down abnormal c-Abl protein.
Dr Simon Stott appointed Director of Research
Cure Parkinson’s is pleased to announce that Dr Simon Stott has been promoted to the role of Director of Research.